Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-05

FDA Approved: ALKINDI SPRINKLE — Supplemental Application (Eton Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ALKINDI SPRINKLE (hydrocortisone) from Eton Pharmaceuticals, expanding or updating its labeled use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALKINDI SPRINKLE (HYDROCORTISONE)

Snippet

SUPPL AP for ALKINDI SPRINKLE (HYDROCORTISONE)